ROCKVILLE, Md. – On August 13, 2026, the American Society of Human Genetics (ASHG) announced the recipients...
Nana Muazin
The biotechnology sector in 2026 has entered a period of extraordinary capital concentration, defined by a "flight...
In a high-stakes appeal to the United States Congress, the metastatic breast cancer (MBC) advocacy organization METAvivor...
In the annals of surgical history, there are rare moments that redefine the boundary between the impossible...
By Jonathan Gardner Published September 17, 2026 In a move that signals a fundamental shift in the...
GENEVA, 17 October 2024 — In a significant demonstration of commitment to global health security, France and...
For thousands of families navigating the "diagnostic odyssey"—a grueling, years-long journey to identify the cause of a...
A groundbreaking shift in how we understand Alzheimer’s disease (AD) is emerging from the field of plastic...
In the heart of the Wiregrass region—a sprawling agricultural expanse known for its deep-rooted history in peanut...
As the popularity of glucagon-like peptide-1 (GLP-1) receptor agonists—such as semaglutide and liraglutide—reaches an all-time high, the...
